Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 0 | 6,720,803 | +6,720,803 | 0 | 771,683 | 36.44% | +771,683 |
| Xilio Therapeutics Inc | 9,105,451 | 650,389 | -8,455,062 | 5,829 | 5,470 | 0.26% | -360 |
| Kyverna Therapeutics Inc | 4,126,119 | 4,126,119 | 0 | 38,786 | 35,608 | 1.68% | -3,177 |
| Assembly Biosciences Inc | 4,505,391 | 4,505,391 | 0 | 153,228 | 125,025 | 5.90% | -28,204 |
| Galapagos NV(LKFT) | 16,707,477 | 16,707,477 | 0 | 550,616 | 501,224 | 23.67% | -49,392 |
| Arcus Biosciences Inc(RCUS) | 31,424,760 | 31,424,760 | 0 | 748,852 | 678,775 | 32.05% | -70,077 |
| ARCELLX INC COMMON STOCK | 6,720,803 | 0 | -6,720,803 | 438,196 | 0 | — | -438,196 |